Protein truncation test of LYST reveals heterogenous mutations in patients with Chediak-Higashi syndrome

Blood. 2000 Feb 1;95(3):979-83.

Abstract

Chediak-Higashi syndrome (CHS) is a rare autosomal recessive disorder in which an immune deficiency occurs in association with pigmentation abnormalities. Most patients who do not undergo bone marrow transplantation die of a lymphoproliferative syndrome, though some patients with CHS have a relatively milder clinical course of the disease. The large size of the LYST gene, defective in CHS, has made it difficult to screen for mutations in a large number of patients. Only 8 mutations have been identified so far, and all lead to a truncated LYST protein. We conducted protein truncation tests on this gene in 8 patients with CHS. Different LYST mutations were identified in all subjects through this approach, strengthening the observation of a high frequency of truncated LYST proteins as the genetic cause of CHS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Chediak-Higashi Syndrome / complications
  • Chediak-Higashi Syndrome / genetics*
  • Chediak-Higashi Syndrome / metabolism
  • Child
  • Child, Preschool
  • Codon / genetics
  • Epstein-Barr Virus Infections / complications
  • Female
  • Humans
  • Infant
  • Lymphoproliferative Disorders / etiology
  • Lysosomes / metabolism
  • Male
  • Proteins / chemistry
  • Proteins / genetics*
  • RNA, Messenger / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sequence Deletion
  • Terminator Regions, Genetic*
  • Vesicular Transport Proteins

Substances

  • Codon
  • LYST protein, human
  • Proteins
  • RNA, Messenger
  • Vesicular Transport Proteins